Clinical Trials

There
is 1 clinical trial
for endometrial adenosquamous carcinoma, of which 1
is
open and 0
are
completed or closed.
Of the
trial that contains
endometrial adenosquamous carcinoma as an inclusion criterion, 1 is phase 2 (1 open).

Onc201
is the most common
intervention in
endometrial adenosquamous carcinoma clinical trials.

References

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.